These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 20009893

  • 1. Kallikrein 4 overexpression in endometrial carcinoma and upregulation by estrogen via mitogen-activated protein kinase signal pathway.
    Zhang SQ, Cai B, Liu L, He YY, Yang YX, Wan XP.
    Int J Gynecol Cancer; 2009 Nov; 19(8):1377-83. PubMed ID: 20009893
    [Abstract] [Full Text] [Related]

  • 2. Crosstalk between estrogen receptor and mitogen-activated protein kinase signaling in the development and progression of endometrial cancer.
    Zhou L, Cai B, Bao W, He YY, Chen XY, Yang YX, Liu XL, Wan XP.
    Int J Gynecol Cancer; 2011 Nov; 21(8):1357-65. PubMed ID: 21720253
    [Abstract] [Full Text] [Related]

  • 3. Expression of receptor-binding cancer antigen expressed on SiSo cells and estrogen receptor subtypes in the normal, hyperplastic, and carcinomatous endometrium.
    Zhou XH, Teng XD, Song WY, Wu YJ.
    Int J Gynecol Cancer; 2008 Nov; 18(1):152-8. PubMed ID: 17466050
    [Abstract] [Full Text] [Related]

  • 4. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.
    Dong Y, Kaushal A, Bui L, Chu S, Fuller PJ, Nicklin J, Samaratunga H, Clements JA.
    Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z, Yin L, Zhou X, Zhu Y, Zhu D, Yu Y, Feng Y.
    Cancer; 2006 Aug 15; 107(4):746-56. PubMed ID: 16826583
    [Abstract] [Full Text] [Related]

  • 6. Kallikrein 4 (KLK4), a new member of the human kallikrein gene family is up-regulated by estrogen and progesterone in the human endometrial cancer cell line, KLE.
    Myers SA, Clements JA.
    J Clin Endocrinol Metab; 2001 May 15; 86(5):2323-6. PubMed ID: 11344246
    [Abstract] [Full Text] [Related]

  • 7. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.
    Liu Z, Qi S, Zhao X, Li M, Ding S, Lu J, Zhang H.
    Oncotarget; 2016 Apr 19; 7(16):21315-31. PubMed ID: 26824324
    [Abstract] [Full Text] [Related]

  • 8. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
    Gungorduk K, Ertas IE, Sahbaz A, Ozvural S, Sarica Y, Ozdemir A, Sayhan S, Gokcu M, Yilmaz B, Sanci M, Inan S, Harma M, Yildirim Y.
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug 19; 179():147-52. PubMed ID: 24965996
    [Abstract] [Full Text] [Related]

  • 9. [Estradiol activates MAPK signaling pathway by estrogen induced VEGF and bFGF in endometrial cancer cells].
    Lu Y, Jiang S, Zhang J, Song H, Li L.
    Zhonghua Fu Chan Ke Za Zhi; 2014 Dec 19; 49(12):925-31. PubMed ID: 25608994
    [Abstract] [Full Text] [Related]

  • 10. Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway.
    He YY, Cai B, Yang YX, Liu XL, Wan XP.
    Cancer Sci; 2009 Jun 19; 100(6):1051-61. PubMed ID: 19432902
    [Abstract] [Full Text] [Related]

  • 11. Coexpression index of estrogen receptor alpha mRNA isoforms in simple, complex hyperplasia without atypia, complex atypical hyperplasia and adenocarcinoma.
    Witek A, Paul-Samojedny M, Stojko R, Seifert B, Mazurek U.
    Gynecol Oncol; 2007 Aug 19; 106(2):407-12. PubMed ID: 17561234
    [Abstract] [Full Text] [Related]

  • 12. Activated leukocyte cell adhesion molecule expression is up-regulated in the development of endometrioid carcinoma.
    Liang S, Huang C, Jia S, Wang B.
    Int J Gynecol Cancer; 2011 Apr 19; 21(3):523-8. PubMed ID: 21430457
    [Abstract] [Full Text] [Related]

  • 13. PINCH protein expression in normal endometrium, atypical endometrial hyperplasia and endometrioid endometrial carcinoma.
    Zhang HZ, Li XH, Zhang X, Zhang ZY, Meng YL, Xu SW, Zheng Y, Zhu ZL, Cui DS, Huang LX, Yan BY, Sun XF.
    Chemotherapy; 2010 Apr 19; 56(4):291-7. PubMed ID: 20714146
    [Abstract] [Full Text] [Related]

  • 14. Expression of maspin in endometrioid adenocarcinoma of endometrium.
    Li HW, Leung SW, Chan CS, Yu MM, Wong YF.
    Oncol Rep; 2007 Feb 19; 17(2):393-8. PubMed ID: 17203179
    [Abstract] [Full Text] [Related]

  • 15. The role of hepatocyte growth factor activator inhibitor (HAI)-1 and HAI-2 in endometrial cancer.
    Nakamura K, Hongo A, Kodama J, Hiramatsu Y.
    Int J Cancer; 2011 Jun 01; 128(11):2613-24. PubMed ID: 20715109
    [Abstract] [Full Text] [Related]

  • 16. Estrogen receptor beta (ERbeta) in endometrial simple hyperplasia and endometrioid carcinoma.
    Chakravarty D, Srinivasan R, Ghosh S, Rajwanshi A, Gopalan S.
    Appl Immunohistochem Mol Morphol; 2008 Dec 01; 16(6):535-42. PubMed ID: 18931615
    [Abstract] [Full Text] [Related]

  • 17. Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium.
    Erkanli S, Kayaselcuk F, Kuscu E, Bagis T, Bolat F, Haberal A, Demirhan B.
    Int J Gynecol Cancer; 2006 Dec 01; 16(3):1412-8. PubMed ID: 16803539
    [Abstract] [Full Text] [Related]

  • 18. Aberrant expression of the von Hippel-Lindau gene in human endometrial hyperplasia and endometrial carcinoma.
    Xu JY, Zhu WJ, Cao XZ, Li XF, Wu J.
    Int J Gynecol Cancer; 2011 Apr 01; 21(3):430-4. PubMed ID: 21436690
    [Abstract] [Full Text] [Related]

  • 19. Laminin C1 expression by uterine carcinoma cells is associated with tumor progression.
    Kashima H, Wu RC, Wang Y, Sinno AK, Miyamoto T, Shiozawa T, Wang TL, Fader AN, Shih IeM.
    Gynecol Oncol; 2015 Nov 01; 139(2):338-44. PubMed ID: 26343160
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical analysis of c-myc, c-jun and estrogen receptor in normal, hyperplastic and neoplastic endometrium.
    Bircan S, Ensari A, Ozturk S, Erdogan N, Dundar I, Ortac F.
    Pathol Oncol Res; 2005 Nov 01; 11(1):32-9. PubMed ID: 15800680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.